IRIS
DE MURO, Pierina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.177
AS - Asia 2.068
EU - Europa 1.259
SA - Sud America 1.259
AF - Africa 75
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 7
Totale 7.854
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.106
BR - Brasile 1.136
SG - Singapore 781
CN - Cina 751
UA - Ucraina 524
HK - Hong Kong 216
DE - Germania 183
IT - Italia 124
SE - Svezia 100
FI - Finlandia 87
FR - Francia 73
GB - Regno Unito 69
VN - Vietnam 62
TR - Turchia 55
AR - Argentina 47
CA - Canada 31
IQ - Iraq 27
ZA - Sudafrica 27
BE - Belgio 24
MX - Messico 24
PK - Pakistan 22
VE - Venezuela 22
BD - Bangladesh 21
EC - Ecuador 20
KR - Corea 20
IN - India 19
RU - Federazione Russa 18
MA - Marocco 17
JP - Giappone 16
PL - Polonia 14
UZ - Uzbekistan 14
AE - Emirati Arabi Uniti 8
ES - Italia 8
EU - Europa 8
ID - Indonesia 8
KE - Kenya 8
PE - Perù 8
CL - Cile 7
JO - Giordania 7
PY - Paraguay 7
AU - Australia 6
CO - Colombia 6
NP - Nepal 6
TN - Tunisia 6
DZ - Algeria 5
IL - Israele 5
NL - Olanda 5
AT - Austria 4
DO - Repubblica Dominicana 4
GR - Grecia 4
KZ - Kazakistan 4
AZ - Azerbaigian 3
BG - Bulgaria 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
EG - Egitto 3
GE - Georgia 3
LB - Libano 3
LT - Lituania 3
OM - Oman 3
UY - Uruguay 3
AL - Albania 2
BO - Bolivia 2
CG - Congo 2
CH - Svizzera 2
CI - Costa d'Avorio 2
GT - Guatemala 2
HR - Croazia 2
JM - Giamaica 2
KG - Kirghizistan 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
GA - Gabon 1
GY - Guiana 1
HN - Honduras 1
IR - Iran 1
KN - Saint Kitts e Nevis 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
MR - Mauritania 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 7.852
Salva come PNG Salva come JPEG
Città #
Dallas 970
Singapore 444
Chandler 435
Jacksonville 316
Hong Kong 216
Princeton 158
Nanjing 147
Beijing 135
Dearborn 104
Ashburn 91
São Paulo 87
New York 85
Ann Arbor 83
Wilmington 72
Nanchang 65
Sassari 59
Shanghai 45
Boardman 43
Shenyang 43
Hebei 39
Rio de Janeiro 39
Los Angeles 32
Woodbridge 31
Changsha 30
Belo Horizonte 29
Tianjin 29
Ho Chi Minh City 27
Ningbo 26
Brussels 24
Izmir 24
Campinas 22
Mountain View 22
Santa Clara 22
Hangzhou 21
Curitiba 20
Johannesburg 20
Seoul 20
Buffalo 19
Jinan 19
Zhengzhou 18
Jiaxing 17
Tokyo 15
Baghdad 14
Kunming 14
Warsaw 14
Andover 13
Brasília 13
Norwalk 13
San Francisco 13
Tashkent 13
Toronto 13
Goiânia 12
Columbus 11
London 11
Council Bluffs 10
Guangzhou 10
Guarulhos 10
Orem 10
Porto Alegre 10
Ribeirão Preto 10
Sorocaba 10
The Dalles 10
Betim 9
Brooklyn 9
Casablanca 9
Helsinki 9
Manaus 8
Stockholm 8
São José dos Campos 8
Campo Grande 7
Caxias do Sul 7
Denver 7
Fortaleza 7
Montreal 7
Nairobi 7
Osasco 7
Phoenix 7
Quito 7
Santo André 7
Villiers-sur-marne 7
Americana 6
Amman 6
Auburn Hills 6
Blumenau 6
Boston 6
Carapicuíba 6
Chennai 6
Dhaka 6
Florianópolis 6
Franca 6
Istanbul 6
Itajaí 6
Lanzhou 6
Lima 6
Recife 6
San Jose 6
Taizhou 6
Uberlândia 6
Atlanta 5
Bauru 5
Totale 4.652
Salva come PNG Salva come JPEG
Nome #
Albumin-bound low molecular weight thiols analysis in plasma and carotid plaques by CE 181
Apolipoprotein Profiles in Atherosclerotic Disease 164
Identification of differentially expressed plasma proteins in atherosclerotic patients with type 2 diabetes 151
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-g (MIG) 141
Apolipoprotein Profiles in Atherosclerotic Disease 141
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 139
Evaluation of Early Markers of Nephropathy in Patients with Type 2 Diabetes Mellitus 138
A longitudinal evaluation of urinary glycosaminoglycan excretion in normoalbuminuric type 1 diabetic patients 135
DNA polymorphisms in north-Sardinian newborns and their linkage with abnormal gamma globin gene arrangements and with B°-thalassemia 125
Polymorphism of foetal haemoglobin in the sardinian Beta+-Thalassaemia. 125
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 124
Buoyant density of Lp(a) subclasses in hypercholesterolemia 123
Dna polymorphisms in north sardinian newborns and their linkage with abnormal globin gene arrangiements and with beta°-thalassemia 121
Glycosaminoglycan and transforming growth factor beta 1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy 121
IDENTIFICATION OF POTENTIAL BIOMARKERS IN MYASTHENIA GRAVIS DISEASE BY PLASMA PROTEOMIC ANALYSIS 121
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoing carotid endarterectomy 120
Development of a method for urine bikunin/urinary trypsin inhibitor (UTI) quantitation and structural characterization: Application to type 1 and type 2 diabetes 118
Levels of Urinary Trypsin Inhibitor and Structure of Its Chondroitin Sulphate Moiety in Type 1 and Type 2 Diabetes 117
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 117
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-γ (MIG). 117
Quali-quantitative analysis of urinary glycosaminoglycans for monitoring glomerular inflammatory activity 117
Impact of first trimester fasting glycemic levels on expression of proteoglycans in pregnancy 113
Characterization of glycosaminoglycans in human plasma from patients receiving haemodyalisis and their interaction with human LDL 113
Polymorphism of foetal haemoglobin in the Sardinian B+-thalassemia 111
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoingcarotid endarterectomy 111
Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential 111
Urinary glycosaminoglycan and proteoglycan excretion in normoalbuminuric patients with type 1 diabetes mellitus 109
Sulphated polysaccharide content and localization in some marine sponge species. 108
Proteomic analysis of plasma apolipoproteins in relation to atherosclerosis 108
Characterization of a protein-glycosaminoglycan complex in urine from healthy subjects 107
Blood and urine glycosaminoglycan variations during different hypocholesterolemic therapies in type 2 diabetic patients 104
Significance of urinary glycosaminoglycans/proteoglycans in the evaluation of type 1 and type 2 diabetes complications 103
Glycosaminoglycan and transforming growth factor beta1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy. IF 2009: 3.970 JCR: Q1 100
Hb G-Philadelphia, or [alpha68(E17)AsnLys], in North Sardinia: detection by isoelectric focusing and HPLC of tryptic peptides 99
Glycosamynoglycan diversity in sponge extracellular matrix 99
Urinary glycosaminoglycan composition in chronic glomerulonephritis 99
Proteomic analysis of plasma-purified VLDL, LDL, and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 98
Plasma PP13, urinary GAGs/PGs as early markers of pre-eclampsia 96
Structural and functional modifications of human aorta proteoglycans in atherosclerosis 95
Urine bikunin as a marker of renal impairment in Fabry's disease 94
Ruolo dei proteoglicani nella medicina della riproduzione 94
Haematological and biosynthetic features of beta°-thalassemia with an associated alpha-thalassemia heterozygosity in Sardinia 92
GAG and protein composition of GAG-protein complexes from normal human plasma 91
Atherosclerotic modifications of human proteoglycans 91
QUANTITATIVE AND STRUCTURAL ANALYSES OF URINARY TRYPSIN INHIBITOR IN TYPE 1 AND TYPE 2 DIABETES 91
Urinary glycosaminoglycans in patients with systemic lupus erythematosus 89
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients. 89
Urine Bikunin Quantitation and Structural Characterization in Type I and Type II Diabetes Patients 89
Role of the small proteoglycan bikunin in human reproduction 88
Preliminary investigations of LDL interactions with proteoglycans extracted from human aortic walls with different atherosclerotic lesions 88
Plasma GAG-protein complexes modify chemical and physical properties of human LDL 87
Urinary excretion of GAGs during hypocholesterolemic therapy 87
Evidences that atherosclerotic lesion involves modifications of arterial wall proteoglycans, affecting their interactions with LDL 87
DNA polymorphisms in North Sardinian newborns and their linkage with abnormal gamma globin gene arrangements and with betao-thalassemia. 86
Ldl interaction with proteoglycans isolated from human aortas with different atherosclerotic involvement 85
Iloprost therapy acutely decreases oxidative stress in patients affected by systemic sclerosis 84
The gamma globin chain heterogeneity of the Sardinian newborn baby. Hemoglobin, 10:519-528, 1986. 83
Plasma levels of C-reactive protein, leptin and glycosaminoglycans during spontaneous menstrual cycle: differences between ovulatory and anovulatory cycles 80
Diversità molecolare negli invertebrati marini: screening dei glicosaminoglicani in spugne del Mediterraneo occidentale 80
Proteoglicani e diabete gestazionale: dati preliminari 80
Urinary transaforming growth factor beta 1 in various types of nephropathy 79
Protein sulfhydryl group oxidation and mixed-disulfide modifications in stable and unstable human carotid plaques 79
Urinary transforming growth factor-beta 1 in various types of nephropathy 78
Post-translational modifications of proteoglycans during the development of atherosclerotic lesion 76
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-ϒ (MIG) 76
The gamma globin chain heterogeneity of the Sardinian newborn baby 74
Urinary glycosaminoglycansin patients with systemic lupus erytematosus 74
Glycosaminoglycan biodiversity in W-Mediterranean marine sponges. 73
Modification of low density lipoprotein induced by the interaction with standard GAGs 72
Fine structure of glycosaminoglycans from fresh and decellularized porcine cardiac valves and pericardium 70
Hematological and biosynthetic features of betao-thalassemia with an associated beta-thalassemia heterozygosity in Sardinia. 69
Proteomic analysis of plasma-purified VLDL, LDL and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 69
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients 69
Glycosaminoglycans and fabry’s disease 68
Investigations on PGs extracted from human aorta of different age and with different atherosclerotic lesions 67
Modifications of low density lipoprotein induced by the interaction with human plasma glycosaminoglycan-protein complexes 66
Glycosaminoglycan diversity in sponge extracellular matrix 65
Plasma Levels of C-Reactive Protein, Leptin and Glycosaminoglycans During Spontaneous Menstrual Cycle: Differences Between Ovulatory and Anovulatory Cycles 65
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 64
Human LDL binding to plasma high charge glycosaminoglycan-protein complexes 61
Totale 7.889
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.797
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.797
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021329 0 0 0 0 0 19 85 4 95 98 16 12
2021/2022396 62 3 0 11 6 2 24 26 46 25 39 152
2022/2023802 84 54 14 149 82 141 0 93 130 9 28 18
2023/2024227 45 19 7 4 48 50 1 11 0 1 23 18
2024/20252.307 18 17 128 30 110 48 192 368 827 403 108 58
2025/20262.075 119 774 351 376 264 191 0 0 0 0 0 0
Totale 7.889